IMPURITIES AVAILABLE FOR 'Cenicriviroc'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Cenicriviroc. Cenicriviroc is an experimental oral medication that acts as a dual antagonist of CCR2 and CCR5 chemokine receptors. It has been investigated for the treatment of nonalcoholic steatohepatitis (NASH), liver fibrosis, and certain inflammatory or infectious conditions. By blocking CCR2 and CCR5, cenicriviroc reduces recruitment of inflammatory cells to the liver and other tissues, thereby lowering inflammation and fibrosis progression. It was initially developed as an anti-HIV drug due to its CCR5 inhibition but showed greater potential in liver disease. Clinical trials have suggested improvement in fibrosis without worsening of NASH. The drug is taken orally and is generally well tolerated, with side effects including headache, fatigue, and gastrointestinal disturbances. Research is ongoing to establish its long-term safety and efficacy. Buy high quality Cenicriviroc from Omsynth Lifesciences.